Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - pioglitazonum - compresse - pioglitazonum 15 mg ut pioglitazoni hydrochloridum, lactosum monohydricum 37.77 mg, carmellosum calcicum, hydroxypropylcellulosum, magnesii stearas, pro compresso. - farmaco antidiabetico orale - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - pioglitazonum - compresse - pioglitazonum 30 mg ut pioglitazoni hydrochloridum, lactosum monohydricum 75.54 mg, carmellosum calcicum, hydroxypropylcellulosum, magnesii stearas, pro compresso. - farmaco antidiabetico orale - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - pioglitazonum - compresse - pioglitazonum 45 mg ut pioglitazoni hydrochloridum, lactosum monohydricum 113.31 mg, carmellosum calcicum, hydroxypropylcellulosum, magnesii stearas, pro compresso. - farmaco antidiabetico orale - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - ropinirolum - retardtabletten - ropinirolum 2 mg ut ropiniroli hydrochloridum, ammonio methacrylatis copolymerum b, hypromellosum, natrii laurilsulfas, copovidonum, magnesii stearas, Überzug: lactosum monohydricum 1.8 mg, hypromellosum, triacetinum, e 171, e 172 (rubrum), pro compresso obducto corresp. natrium 0.538 mg. - morbo di parkinson - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - ropinirolum - retardtabletten - ropinirolum 4 mg ut ropiniroli hydrochloridum, ammonio methacrylatis copolymerum b, hypromellosum, natrii laurilsulfas, copovidonum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 110 0.81 mg, e 132, e 171, pro compresso obducto corresp. natrium 1.077 mg. - morbo di parkinson - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - ropinirolum - retardtabletten - ropinirolum 8 mg ut ropiniroli hydrochloridum, ammonio methacrylatis copolymerum b, hypromellosum, natrii laurilsulfas, copovidonum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, e 172 (rubrum), e 172 (nigrum), e 172 (flavum), pro compresso obducto corresp. natrium 2.153 mg. - morbo di parkinson - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - omeprazolum - capsule gastroresistenti - omeprazolum 10 mg, sacchari sphaerae corresp. saccharum 40.01 mg, povidonum k 30, natrii laurilsulfas, carboxymethylamylum natricum a, trinatrii phosphas dodecahydricus, hypromellosum, triethylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum, talcum, e 171, kapselhülle: aqua, gelatina, e 171, drucktinte: lacca, ethanolum anhydricum, alcohol isopropylicus, propylenglycolum, alcohol butylicus, ammonii hydroxidum, kalii hydroxidum, aqua purificata, e 172 (nigrum), pro capsula corresp. natrium 0.45 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - omeprazolum - capsule gastroresistenti - omeprazolum 20 mg, sacchari sphaerae corresp. saccharum 80.02 mg, povidonum k 30, natrii laurilsulfas, carboxymethylamylum natricum a, trinatrii phosphas dodecahydricus, hypromellosum, triethylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum, talcum, e 171, kapselhülle: aqua, gelatina, e 171, drucktinte: lacca, ethanolum anhydricum, alcohol isopropylicus, propylenglycolum, alcohol butylicus, ammonii hydroxidum, kalii hydroxidum, aqua purificata, e 172 (nigrum), pro capsula corresp. natrium 1.51 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - omeprazolum - capsule gastroresistenti - omeprazolum 40 mg, sacchari sphaerae corresp. saccharum 160.05 mg, povidonum k 30, natrii laurilsulfas, carboxymethylamylum natricum a, trinatrii phosphas dodecahydricus, hypromellosum, triethylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum, talcum, e 171, kapselhülle: aqua, gelatina, e 171, drucktinte: lacca, ethanolum anhydricum, alcohol isopropylicus, propylenglycolum, alcohol butylicus, ammonii hydroxidum, kalii hydroxidum, aqua purificata, e 172 (nigrum), pro capsula corresp. natrium 3.03 mg. - ulcustherapie, sindrome di zollinger-ellison-syndrom - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - mometasoni-17 furoas - spray nasale - mometasoni-17 furoas 50 µg, conserv.: benzalkonii chloridi soluzione, excipiens a sospensione dosi, dosi per la nave 140. - rinite, nasenpolypen - synthetika